Insulin detemir (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Insulin detemir" in English language version.

refsWebsite

Global rank English rank

3medicines.org.uk

3,823^rd place

2,387^th place

3nih.gov

4^th place

2drugs.com

399^th place

333^rd place

2clincalc.com

3,912^th place

2,496^th place

2web.archive.org

1^st place

2fda.gov

447^th place

338^th place

1europa.eu

68^th place

117^th place

1handle.net

102^nd place

76^th place

1doi.org

2^nd place

clincalc.com

"The Top 300 of 2021". ClinCalc. Archived from the original on 15 January 2024. Retrieved 14 January 2024.
"Insulin Detemir - Drug Usage Statistics". ClinCalc. Retrieved 14 January 2024.

doi.org

Hemmingsen B, Metzendorf MI, Richter B (March 2021). "(Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus". The Cochrane Database of Systematic Reviews. 3 (3): CD013498. doi:10.1002/14651858.cd013498.pub2. PMC 94220. PMID 33662147.

drugs.com

"Insulin Detemir Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 3 March 2019.
"Insulin detemir (Levemir) Use During Pregnancy". Drugs.com. 12 June 2019. Retrieved 14 April 2020.

europa.eu

ema.europa.eu

"Levemir EPAR". European Medicines Agency (EMA). Retrieved 14 April 2020.

fda.gov

accessdata.fda.gov

"Drug Approval Package: Levemir Insulin Detemir[rDNA origin] Injection; NDA #021536". U.S. Food and Drug Administration (FDA). 26 July 2005. Retrieved 14 April 2020.

fda.gov

"FDA Issues Public Health Advisory Regarding Levemir Insulin". Food and Drug Administration. 13 June 2009. Archived from the original on 17 June 2009. Retrieved 9 March 2019.

handle.net

hdl.handle.net

World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.

medicines.org.uk

"Levemir FlexPen 100 units/ml solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC)". (emc). 21 May 2018. Retrieved 14 April 2020.
"Levemir InnoLet 100 units/ml solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC)". (emc). 21 May 2018. Retrieved 14 April 2020.
"Levemir Penfill 100 units/ml solution for injection in cartridge - Summary of Product Characteristics (SmPC)". (emc). 21 May 2018. Retrieved 14 April 2020.

nih.gov

dailymed.nlm.nih.gov

"Levemir- insulin detemir injection, solution". DailyMed. 24 March 2020. Retrieved 19 October 2020.

ncbi.nlm.nih.gov

Hemmingsen B, Metzendorf MI, Richter B (March 2021). "(Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus". The Cochrane Database of Systematic Reviews. 3 (3): CD013498. doi:10.1002/14651858.cd013498.pub2. PMC 94220. PMID 33662147.

pubmed.ncbi.nlm.nih.gov

Hemmingsen B, Metzendorf MI, Richter B (March 2021). "(Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus". The Cochrane Database of Systematic Reviews. 3 (3): CD013498. doi:10.1002/14651858.cd013498.pub2. PMC 94220. PMID 33662147.

web.archive.org

"The Top 300 of 2021". ClinCalc. Archived from the original on 15 January 2024. Retrieved 14 January 2024.
"FDA Issues Public Health Advisory Regarding Levemir Insulin". Food and Drug Administration. 13 June 2009. Archived from the original on 17 June 2009. Retrieved 9 March 2019.